ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 176 filers reported holding ZAI LAB LTD in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,093 | +39.0% | 1,896 | +58.5% | 0.00% | – |
| Q2 2023 | $33,165 | +11.3% | 1,196 | +33.5% | 0.00% | – |
| Q1 2023 | $29,802 | +140.9% | 896 | +122.3% | 0.00% | – |
| Q4 2022 | $12,372 | -38.1% | 403 | -35.2% | 0.00% | – |
| Q3 2022 | $20,000 | +150.0% | 622 | +134.7% | 0.00% | – |
| Q2 2022 | $8,000 | -71.4% | 265 | -57.4% | 0.00% | – |
| Q1 2022 | $28,000 | -3.4% | 622 | +32.1% | 0.00% | – |
| Q4 2021 | $29,000 | +20.8% | 471 | +106.6% | 0.00% | – |
| Q3 2021 | $24,000 | -46.7% | 228 | -9.5% | 0.00% | – |
| Q2 2021 | $45,000 | +18.4% | 252 | -12.5% | 0.00% | – |
| Q1 2021 | $38,000 | -5.0% | 288 | -3.7% | 0.00% | – |
| Q4 2020 | $40,000 | +185.7% | 299 | +74.9% | 0.00% | – |
| Q3 2020 | $14,000 | +100.0% | 171 | +85.9% | 0.00% | – |
| Q2 2020 | $7,000 | – | 92 | +1214.3% | 0.00% | – |
| Q1 2020 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |